RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

The RAPS store will be under maintenance Saturday, 6 June between 6 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > China Announces Electronic Monitoring Deadlines for Imported Drugs

China Announces Electronic Monitoring Deadlines for Imported Drugs

Posted 20 May 2013 | By Louise Zornoza

The China Food and Drug Administration (CFDA) has issued a notice setting deadlines for implementing electronic monitoring for imported essential drugs.

Imported drugs in domestic packaging must comply with electronic monitoring requirements by the end of November 2013, and all other imported drugs by the end of March 2014. The implementation of electronic monitoring is to be done in accordance with the former State Food and Drug Administration notice "on the issuance of guidance on electronic drug supervision." (State Food and Drug Administration [2010] No. 283)

Regulatory Focus newsletters

All the biggest regulatory news and happenings.